Shanghai MicroPort Endovascular MedTech Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai MicroPort Endovascular MedTech has a total shareholder equity of CN¥3.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥4.6B and CN¥637.7M respectively. Shanghai MicroPort Endovascular MedTech's EBIT is CN¥599.0M making its interest coverage ratio -6.2. It has cash and short-term investments of CN¥2.5B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -6.2x |
Cash | CN¥2.50b |
Equity | CN¥3.92b |
Total liabilities | CN¥637.70m |
Total assets | CN¥4.56b |
Recent financial health updates
Recent updates
Investors Met With Slowing Returns on Capital At Shanghai MicroPort Endovascular MedTech (SHSE:688016)
Dec 16Calculating The Fair Value Of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016)
Nov 27Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders
Nov 06There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise
Oct 01Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts
Aug 29Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Financial Position Analysis
Short Term Liabilities: 688016's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥513.6M).
Long Term Liabilities: 688016's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥124.1M).
Debt to Equity History and Analysis
Debt Level: 688016 is debt free.
Reducing Debt: 688016 has not had any debt for past 5 years.
Debt Coverage: 688016 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688016 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 18:00 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicroPort Endovascular MedTech Co., Ltd. is covered by 19 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jingning Long | Chasing Securities |
Jian Jun Zou | Chasing Securities |
Pei Cheng | China Galaxy Securities Co., Ltd. |